Regeneron Pharmaceuticals will release its second-quarter earnings next month, and analysts anticipate a double-digit profit ...

The market expects Regeneron (REGN) to deliver a year-over-year decline in earnings on lower revenues when it reports results ...

Regeneron currently trades at $511.25, down from $610.36 just before the earnings. Should you double down or take your chips? Find out in our full research report (it’s free).